North Crest Asset Manangement, LLC Astrazeneca PLC Transaction History
North Crest Asset Manangement, LLC
- $3.54 Billion
- Q2 2025
A detailed history of North Crest Asset Manangement, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 18,996 shares of AZN stock, worth $1.59 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,996
Previous 19,087
0.48%
Holding current value
$1.59 Million
Previous $1.4 Million
5.35%
% of portfolio
0.04%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.36 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...